(Q47768496)

5 February 2018

title

Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis (English)

1 reference

5 February 2018

relapsing-remitting multiple sclerosis

main subject

multiple sclerosis

0 references

biomarker

0 references

0 references

author name string

Inmaculada Tasset

1

1 reference

5 February 2018

Carmen Bahamonde

2

1 reference

5 February 2018

Eduardo Agüera

3

1 reference

5 February 2018

Cristina Conde

4

1 reference

5 February 2018

Antonio H Cruz

5

1 reference

5 February 2018

Aleyda Pérez-Herrera

6

1 reference

5 February 2018

Félix Gascón

7

1 reference

5 February 2018

Ana I Giraldo

8

1 reference

5 February 2018

María C Ruiz

9

1 reference

5 February 2018

Rafael Lillo

10

1 reference

5 February 2018

Fernando Sánchez-López

11

1 reference

5 February 2018

Isaac Túnez

12

1 reference

5 February 2018

publication date

1 January 2013

1 reference

5 February 2018

published in

Pharmacological Reports

1 reference

5 February 2018

volume

65

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

624-631

1 reference

5 February 2018

NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Monoclonal antibodies in MS: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Oxidative and antioxidative potential of brain microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Assays of glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

The effects of sepsis on mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Mechanisms underlying inflammation in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Oxidative damage in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Role of oxidative stress and inflammation in hypoxia-induced cerebral edema: a molecular approach

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Nrf2:INrf2 (Keap1) signaling in oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Determination of carbonyl content in oxidatively modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Methionine in proteins defends against oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Natalizumab treatment reduces endothelial activity in MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Redox regulation of cellular stress response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Application of manual assessment of oxygen radical absorbent capacity (ORAC) for use in high throughput assay of "total" antioxidant activity of drugs and natural products

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Peripheral oxidative stress in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Important role of oxidative stress biomarkers in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

Radical changes in multiple sclerosis pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971039-9

7 January 2021

10.1016/S1734-1140(13)71039-9

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

23950585

1 reference

5 February 2018